The beneficial effects of n-3 PUFA on reducing the severity of the lipid metabolism disorder and liver damage in C57BL/6 J mice may also be linked to upregulation of the Fra1 gene and attenuated activity of c-Jun and c-Fos [44]. The gene discussed is FOSL1; the disease is Disorder of lipid metabolism.